α-Trinositol inhibits FGF-stimulated growth of smooth muscle and breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 325, Issue 3, 2004, Pages 691-697

  Sirén, Matti J ^a   Vainiomäki, Maija ^b   Väänänen, Kalervo ^b   Härkönen, Pirkko ^b,c  

^a Helsinki Zoo   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Trinositol; FGFs; HPASMC; S115 cells

Indexed keywords

FIBROBLAST GROWTH FACTOR; INOSITOL 1,2,6 TRISPHOSPHATE; WATER;

ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; INOSITOL PHOSPHATES; MICE; MUSCLE, SMOOTH, VASCULAR;

ANIMALIA;

EID: 8444241492     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.087     Document Type: Article

References (42)

1. R.H. Michell Inositol lipids in cellular signalling mechanisms Trends Biochem. Sci. 17 1992 274 276
2. A. Claxson, C. Morris, D. Blake, M. Siren, B. Halliwell, T. Gustafsson, B. Lofkvist, and I. Bergelin The anti-inflammatory effects of d-myo-inositol-1.2.6-trisphosphate (PP56) on animal models of inflammation Agents Actions 29 1990 68 70
3. W. Lingnau, R. McGuire, M. Booke, L.D. Traber, and D.L. Traber Effects of alpha-trinositol on systemic inflammation and renal function in ovine bacterial sepsis Shock 8 1997 179 185
4. H. Nakazawa, T.O. Gustafsson, L.D. Traber, D.N. Herndon, and D.L. Traber alpha-Trinositol decreases lung edema formation after smoke inhalation in an ovine model J. Appl. Physiol. 76 1994 278 282
5. M. Siren, L. Linné, L. Persson, Pharmacological effects of d-myo-inositol-1,2,6, -trisphosphate (PP56), in Inositol Phosphates and Derivatives, Synthesis, Biochemistry and Therapeutic Potential, A. Reitz (Ed.), ACS Symp. Ser. 463 (1991) 103-110
6. D. Bell, and B.J. McDermott d-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling? Gen. Pharmacol. 31 1998 689 696
7. 3H]alpha-trinositol (1d-myo-inositol 1,2,6-trisphosphate) binding sites in human and mammalian tissues J. Pharmacol. Exp. Ther. 273 1995 461 469
8. R. Stricker, E. Westerberg, and G. Reiser Binding sites for alpha-trinositol (inositol 1,2,6-trisphosphate) in porcine tissues; comparison with Ins(1,4,5)P3 and Ins(1,3,4,5)P4-binding sites Br. J. Pharmacol. 117 1996 919 925
9. H. Yoo, B. Fallgren, A. Lindahl, and C. Wahlestedt Characterization of specific binding sites for alpha-trinositol (d-myo-inositol 1,2,6-trisphosphate) in rat tissues Eur. J. Pharmacol. 268 1994 55 63
10. A. Chaudhary, and G.D. Prestwich Photoaffinity analogue for the anti-inflammatory drug alpha-trinositol: synthesis and identification of putative molecular targets Bioconjug. Chem. 8 1997 680 685
11. D.M. Ornitz, and N. Itoh Fibroblast growth factors Genome Biol. 2 2001 REVIEWS3005
12. C.J. Powers, S.W. McLeskey, and A. Wellstein Fibroblast growth factors, their receptors and signaling Endocr. Relat. Cancer 7 2000 165 197
13. A.W. Clowes, M.A. Reidy, and M.M. Clowes Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium Lab. Invest. 49 1983 327 333
14. R.E. Zierler, D.F. Bandyk, B.L. Thiele, and D.E. Strandness Jr. Carotid artery stenosis following endarterectomy Arch. Surg. 117 1982 1408 1415
15. J. Folkman, and M. Klagsbrun Angiogenic factors Science 235 1987 442 447
16. V. Lindner, D.A. Lappi, A. Baird, R.A. Majack, and M.A. Reidy Role of basic fibroblast growth factor in vascular lesion formation Circ. Res. 68 1991 106 113
17. V. Lindner, and M.A. Reidy Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study Circ. Res. 73 1993 589 595
18. W. Casscells, D.A. Lappi, B.B. Olwin, C. Wai, M. Siegman, E.H. Speir, J. Sasse, and A. Baird Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors Proc. Natl. Acad. Sci. USA 89 1992 7159 7163
19. A. Segev, D. Aviezer, M. Safran, Z. Gross, and A. Yayon Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist Cardiovasc. Res. 53 2002 232 241
20. F. Bono, P. Rigon, I. Lamarche, P. Savi, V. Salel, and J.M. Herbert Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells Biochem. J. 326 Pt. 3 1997 661 668
21. V. Lindner, and M.A. Reidy Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor Proc. Natl. Acad. Sci. USA 88 1991 3739 3743
22. D.J. Francis, C.R. Parish, M. McGarry, F.S. Santiago, H.C. Lowe, K.J. Brown, J.A. Bingley, I.P. Hayward, W.B. Cowden, J.H. Campbell, G.R. Campbell, C.N. Chesterman, and L.M. Khachigian Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation Circ. Res. 92 2003 e70 e77
23. M.V. Cronauer, W.A. Schulz, H.H. Seifert, R. Ackermann, and M. Burchardt Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications Eur. Urol. 43 2003 309 319
24. J.A. Takahashi, H. Mori, M. Fukumoto, K. Igarashi, M. Jaye, Y. Oda, H. Kikuchi, and M. Hatanaka Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues Proc. Natl. Acad. Sci. USA 87 1990 5710 5714
25. M. Kornmann, T. Ishiwata, H.G. Beger, and M. Korc Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions Oncogene 15 1997 1417 1424
26. A. Tanaka, A. Furuya, M. Yamasaki, N. Hanai, K. Kuriki, T. Kamiakito, Y. Kobayashi, H. Yoshida, M. Koike, and M. Fukayama High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8 Cancer Res. 58 1998 2053 2056
27. E. Valve, P. Martikainen, J. Seppanen, S. Oksjoki, S. Hinkka, L. Anttila, S. Grenman, P. Klemi, and P. Harkonen Expression of fibroblast growth factor (FGF)-8 isoforms and FGF receptors in human ovarian tumors Int. J. Cancer 88 2000 718 725
28. E.M. Valve, M.T. Nevalainen, M.J. Nurmi, M.K. Laato, P.M. Martikainen, and P.L. Harkonen Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer Lab. Invest. 81 2001 815 826
29. T.J. Dorkin, M.C. Robinson, C. Marsh, A. Bjartell, D.E. Neal, and H.Y. Leung FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease Oncogene 18 1999 2755 2761
30. V.J. Gnanapragasam, M.C. Robinson, C. Marsh, C.N. Robson, F.C. Hamdy, and H.Y. Leung FGF8 isoform b expression in human prostate cancer Br. J. Cancer 88 2003 1432 1438
31. D.B. Volkin, P.K. Tsai, J.M. Dabora, J.O. Gress, C.J. Burke, R.J. Linhardt, and C.R. Middaugh Physical stabilization of acidic fibroblast growth factor by polyanions Arch. Biochem. Biophys. 300 1993 30 41
32. J.K. Ruohola, E.M. Valve, S. Vainikka, K. Alitalo, and P.L. Harkonen Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells Endocrinology 136 1995 2179 2188
33. D. Gospodarowicz, N. Ferrara, T. Haaparanta, and G. Neufeld Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells Eur. J. Cell Biol. 46 1988 144 151
34. H.A. Weich, N. Iberg, M. Klagsbrun, and J. Folkman Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells Growth Factors 2 1990 313 320
35. M.M. Mattila, J.K. Ruohola, E.M. Valve, M.J. Tasanen, J.A. Seppanen, and P.L. Harkonen FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells Oncogene 20 2001 2791 2804
36. A. Tanaka, K. Miyamoto, N. Minamino, M. Takeda, B. Sato, H. Matsuo, and K. Matsumoto Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells Proc. Natl. Acad. Sci. USA 89 1992 8928 8932
37. D.M. Ornitz, J. Xu, J.S. Colvin, D.G. McEwen, C.A. MacArthur, F. Coulier, G. Gao, and M. Goldfarb Receptor specificity of the fibroblast growth factor family J. Biol. Chem. 271 1996 15292 15297
38. C.A. MacArthur, A. Lawshe, J. Xu, S. Santos-Ocampo, M. Heikinheimo, A.T. Chellaiah, and D.M. Ornitz FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development Development 121 1995 3603 3613
39. X. Xin, A.D. Johnson, T. Scott-Burden, D. Engler, and W. Casscells The predominant form of fibroblast growth factor receptor expressed by proliferating human arterial smooth muscle cells in culture is type I Biochem. Biophys. Res. Commun. 204 1994 557 564
40. T. Miyamoto, I. Leconte, J.L. Swain, and J.C. Fox Autocrine FGF signaling is required for vascular smooth muscle cell survival in vitro J. Cell Physiol. 177 1998 58 67
41. D. Berry, Z. Shriver, B. Natke, C.P. Kwan, G. Venkataraman, and R. Sasisekharan Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1 Biochem. J. 373 2003 241 249
42. I. Vlodavsky, and Y. Friedmann Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis J. Clin. Invest. 108 2001 341 347